Participation Form

We will notify the Study Coordinator for "A Study to Determine the Most Effective Sequence of Treatment with Pembrolizumab abd Standard of Care Chemotherapy in Patients with Non-Small Cell Lung Cancer," on your behalf, that you would like to participate in this study.

Please fill out the form below and click "Submit" to send a notification request.

or Cancel

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.